273 related articles for article (PubMed ID: 25402673)
1. The test-retest reliability of the Peyronie's disease questionnaire.
Coyne KS; Currie BM; Thompson CL; Smith TM
J Sex Med; 2015 Feb; 12(2):543-8. PubMed ID: 25402673
[TBL] [Abstract][Full Text] [Related]
2. Bother and distress associated with Peyronie's disease: validation of the Peyronie's disease questionnaire.
Hellstrom WJ; Feldman R; Rosen RC; Smith T; Kaufman G; Tursi J
J Urol; 2013 Aug; 190(2):627-34. PubMed ID: 23376705
[TBL] [Abstract][Full Text] [Related]
3. Responsiveness of the Peyronie's Disease Questionnaire (PDQ).
Coyne KS; Currie BM; Thompson CL; Smith TM
J Sex Med; 2015 Apr; 12(4):1072-9. PubMed ID: 25664497
[TBL] [Abstract][Full Text] [Related]
4. Peyronie's Disease Questionnaire (PDQ): Spanish translation and validation.
García-Gómez B; Martínez-Salamanca JI; Sarquella-Geli J; Justo-Quintas J; García-Rojo E; Fernández-Pascual E; Ruíz-Castañé E; Romero-Otero J
Int J Impot Res; 2022 Aug; 34(5):501-504. PubMed ID: 34282285
[TBL] [Abstract][Full Text] [Related]
5. Baseline characteristics from an ongoing phase 3 study of collagenase clostridium histolyticum in patients with Peyronie's disease.
Gelbard M; Hellstrom WJ; McMahon CG; Levine LA; Smith T; Tursi J; Kaufman G; Goldstein I
J Sex Med; 2013 Nov; 10(11):2822-31. PubMed ID: 24112401
[TBL] [Abstract][Full Text] [Related]
6. Self-report and Clinical Response to Peyronie's Disease Treatment: Peyronie's Disease Questionnaire Results From 2 Large Double-Blind, Randomized, Placebo-Controlled Phase 3 Studies.
Hellstrom WJ; Feldman RA; Coyne KS; Kaufman GJ; Smith TM; Tursi JP; Rosen RC
Urology; 2015 Aug; 86(2):291-8. PubMed ID: 26199168
[TBL] [Abstract][Full Text] [Related]
7. The symptomatic burden of Peyronie's disease at presentation according to patient age: A critical analysis of the Peyronie's disease questionnaire (PDQ) domains.
Cilio S; Fallara G; Capogrosso P; Candela L; Belladelli F; Pozzi E; Corsini C; Raffo M; Schifano N; Boeri L; d'Arma A; Imbimbo C; Mirone V; Montorsi F; Salonia A
Andrology; 2023 Mar; 11(3):501-507. PubMed ID: 36426559
[TBL] [Abstract][Full Text] [Related]
8. Sildenafil 25 mg ODT + Collagenase Clostridium hystoliticum vs Collagenase Clostridium hystoliticum Alone for the Management of Peyronie's Disease: A Matched-Pair Comparison Analysis.
Cocci A; Cito G; Urzì D; Minervini A; Di Maida F; Sessa F; Mari A; Campi R; Falcone M; Capece M; Morelli G; Cacciamani G; Rizzo M; Polito C; Giammusso B; Morgia G; Verze P; Salonia A; Cai T; Mirone V; Mondaini N; Russo GI
J Sex Med; 2018 Oct; 15(10):1472-1477. PubMed ID: 30245025
[TBL] [Abstract][Full Text] [Related]
9. Predictive Factors of Patients' and Their Partners' Sexual Function Improvement After Collagenase Clostridium Histolyticum Injection for Peyronie's Disease: Results From a Multi-Center Single-Arm Study.
Cocci A; Russo GI; Salonia A; Cito G; Regis F; Polloni G; Giubilei G; Cacciamani G; Capece M; Falcone M; Greco I; Timpano M; Minervini A; Gacci M; Cai T; Garaffa G; Giammusso B; Arcaniolo D; Mirone V; Mondaini N
J Sex Med; 2018 May; 15(5):716-721. PubMed ID: 29699756
[TBL] [Abstract][Full Text] [Related]
10. A prospective multicentric international study on the surgical outcomes and patients' satisfaction rates of the 'sliding' technique for end-stage Peyronie's disease with severe shortening of the penis and erectile dysfunction.
Rolle L; Falcone M; Ceruti C; Timpano M; Sedigh O; Ralph DJ; Kuehhas F; Oderda M; Preto M; Sibona M; Gillo A; Garaffa G; Gontero P; Frea B
BJU Int; 2016 May; 117(5):814-20. PubMed ID: 26688436
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of a Novel Penile Traction Device in Men with Peyronie's Disease: A Randomized, Single-Blind, Controlled Trial.
Ziegelmann M; Savage J; Toussi A; Alom M; Yang D; Kohler T; Trost L
J Urol; 2019 Sep; 202(3):599-610. PubMed ID: 30916626
[TBL] [Abstract][Full Text] [Related]
12. Factors Associated With Erectile Dysfunction and the Peyronie's Disease Questionnaire in Patients With Peyronie Disease.
Serefoglu EC; Smith TM; Kaufman GJ; Liu G; Yafi FA; Hellstrom WJG
Urology; 2017 Sep; 107():155-160. PubMed ID: 28554517
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Collagenase Clostridium histolyticum (Xiapex
Cocci A; Di Maida F; Russo GI; Capogrosso P; Francesco L; Rizzo M; Di Mauro M; Salonia A; Cito G; Falcone M; Romano A; Polloni G; Martinez-Salamanca JI; Fernández-Pascual E; Minervini A; Mondaini N
Clin Drug Investig; 2020 Jun; 40(6):583-588. PubMed ID: 32342279
[TBL] [Abstract][Full Text] [Related]
14. Validation of the Italian version of the Peyronie's Disease Questionnaire (PDQ).
Traunero F; Di Grazia M; Ongaro L; Rizzo M; Cocci A; Verze P; Zucchi A; Cai T; Salamè L; Garaffa G; Trombetta C; Liguori G
Int J Impot Res; 2023 Nov; ():. PubMed ID: 37978202
[TBL] [Abstract][Full Text] [Related]
15. Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label study.
Levine LA; Cuzin B; Mark S; Gelbard MK; Jones NA; Liu G; Kaufman GJ; Tursi JP; Ralph DJ
J Sex Med; 2015 Jan; 12(1):248-58. PubMed ID: 25388099
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the Impact of Penile Girth Discrepancy on Patient Bother in Men With Peyronie's Disease: An Observational Study.
Salter CA; Nascimento B; Terrier JE; Taniguchi H; Bernie H; Miranda E; Jenkins L; Schofield E; Mulhall JP
J Sex Med; 2020 Aug; 17(8):1560-1565. PubMed ID: 32576497
[TBL] [Abstract][Full Text] [Related]
17. Penile traction therapy with the new device 'Penimaster PRO' is effective and safe in the stable phase of Peyronie's disease: a controlled multicentre study.
Moncada I; Krishnappa P; Romero J; Torremade J; Fraile A; Martinez-Salamanca JI; Porst H; Levine L
BJU Int; 2019 Apr; 123(4):694-702. PubMed ID: 30365247
[TBL] [Abstract][Full Text] [Related]
18. What do patients with Peyronie's disease expect from therapy? A prospective multi-center study.
Schäfer L; Cremers JF; Witschel B; Schüttfort V; Nieder TO; König F; Vetterlein MW; Gild P; Dahlem R; Fisch M; Kliesch S; Soave A
Andrology; 2024 May; 12(4):821-829. PubMed ID: 37753879
[TBL] [Abstract][Full Text] [Related]
19. Female Partners of Men With Peyronie's Disease Have Impaired Sexual Function, Satisfaction, and Mood, While Degree of Sexual Interference Is Associated With Worse Outcomes.
Davis SN; Ferrar S; Sadikaj G; Gerard M; Binik YM; Carrier S
J Sex Med; 2016 Jul; 13(7):1095-103. PubMed ID: 27209179
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Peyronie's Disease With Collagenase Clostridium histolyticum and Vacuum Therapy: A Randomized, Open-Label Pilot Study.
Ralph DJ; Abdel Raheem A; Liu G
J Sex Med; 2017 Nov; 14(11):1430-1437. PubMed ID: 28974406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
